Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Donald Trump has signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines ...

Drugmakers Pfizer and Flynn Pharma have been ... so they were no longer subject to price regulations. Pfizer hiked the price of the drug between 780% and 1,600%, and also supplied the drug to ...

President Donald Trump on Monday signed a sweeping executive order setting a 30-day deadline for drugmakers to electively ...

President Donald Trump on Monday signed a sweeping executive order setting a 30-day deadline for drugmakers to electively ...

The US-UK trade deal gives the Irish government and EU negotiators some indication of the potential negotiating tactics to ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. | A federal jury in Delaware has ...

Instead, said Kaitin, drugs hit the US market first because the sponsors choose to submit them there first. The advantage of the US is almost wholly down to its lack of price controls, says Kaitin.

The Pediatric Antibiotics Market comprises specialized formulations of beta-lactams, macrolides, cephalosporins, and sulfonamides designed to treat bacterial infections in infants and children. These ...

The order sets a 30-day deadline for drug companies to make "significant progress," or face further action such as tariffs, drug import policies, and pricing regulations ... with Merck rising 5.8%, ...